JENNIFER HARDGROVE: Open Payments
NPI 1033757067 · TUKWILA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 14 payments from 5 companies in 2025. Trend: 2023 $70 · 2024 $533 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $156 |
| Neurocrine BioSciences, Inc. | 3 | $88 |
| Lundbeck LLC | 1 | $31 |
| ABBVIE INC. | 1 | $23 |
Products named: ARISTADA, CAPLYTA, VIVITROL, INGREZZA, REXULTI, MAVYRET, LYBALVI.
Industry payments across WA — which companies pay providers there.
